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Garlic preparations and propranolol (PRO) are agents recognized as cardioprotective and potent antihypertensive agents when
they are used individually. However, there is no report available to explain the role of combined therapy during simultaneous
hypertension and myocardial damage in rats. We aimed to determine the pharmacokinetic and pharmacodynamic interaction
of PRO with garlic homogenate (GH), in rats. The inﬂuence of garlic on pharmacokinetics of PRO was determined by HPLC
method; while pharmacodynamic interaction was studied in animals with hypertension (10% fructose) and myocardial damage
(isoproterenol, 175mgkg−1, s.c. 2 days). PRO was given orally at 10mgkg−1 for 1 week, whereas, GH was administered at
three diﬀerent doses of 125, 250 and 500mgkg−1, p.o. in their respective groups during fourth to sixth week of high fructose
(HF) period, once daily. Systolic blood pressure (SBP), heart rate, cholesterol, triglycerides, glucose, creatine phosphokinase-MB,
lactate dehydrogenase, superoxide dismutase and catalase were measured and histopathological studies were carried out. The
bioavailability and half life of PRO were signiﬁcantly enhanced by 2- and 3-fold, respectively, in animals pretreated with garlic
(250mgkg−1). Administration of PRO and low to moderate doses of GH (125, 250mgkg−1), either alone or together showed fall
in ﬂuid intake and body weight. The combined therapy of GH 250mgkg−1 and PRO was found to be most eﬀective in reducing
SBP, cholesterol, triglycerides and glucose. These observations suggest that careful addition of garlic in moderate doses in PRO
regimen might result in beneﬁcial eﬀect during treatment of hypertensive animals with myocardial damage.
1.Introduction
Currently reliance on natural products is gaining popularity
to combat various physiological threats including oxidative
stress, cardiovascular complexities, cancer insurgence, neu-
rological disorders and immune dysfunction. The use of
traditional remedies may be encountered more frequently
due to an array of scientiﬁc evidence in their favor [1].
While such products had been used with apparent safety in
traditional societies for many centuries, their combination
with modern medicine, poses the possibility of potential
interaction between the two groups of substances. Reports
indicate that ∼15–20% of individuals on prescription med-
ications also use herbal supplements and <40% of patients
disclosetotheirphysicianstheusageofherbalremedies,even
if they experience severe side eﬀects—because of the fear of
censure or rebuke [2]. The problem is further compounded
by the fact that many physicians are themselves not always
familiar with the potential for herb-drug interactions [3].
Hence it is imperative to promote credible research on the
safety and eﬃcacy of combined herb-drug treatment for
variety of ailments including cardiovascular diseases [4].
Propranolol (PRO) is a non-selective beta-blocker, that
is, it blocks the action of epinephrine on both β1-a n d
β2-adrenergic receptors. Despite complete absorption, PRO
has a variable bioavailability due to extensive ﬁrst-pass
metabolism. Hepatic impairment and co-administration
with food appears enhance its bioavailability [5].
Traditionally, garlic (Allium sativum,f a m i l y :Lilliaceae)
and its variety of preparations are widely used as thera-
peutically eﬀective medicament for cardiovascular diseases.
Consumption of garlic and cardiovascular disease progres-
sions is inversely correlated [6] .T h ep r e p a r a t i o n so fg a r l i c
have been widely recognized as agents for prevention and2 Evidence-Based Complementary and Alternative Medicine
treatment of cardiovascular and other metabolic diseases
such as atherosclerosis, arrhythmia, hyperlipidemia, throm-
bosis, hypertension and diabetes [7]. Furthermore, garlic is
alsoreportedtopossesscardioprotective[8],antioxidant[9],
antineoplastic and antimicrobial properties [10]. Further-
more,garlichassigniﬁcantantiarrhythmiceﬀectinbothven-
tricular and supraventricular arrhythmias [11]. It is reported
that chronic use of garlic in moderate doses augments
the endogenous antioxidants activities and depletes the
oxidative damaging eﬀects by either increasing the synthesis
of endogenous antioxidants or decreasing the generation
of oxidants like oxygen free radicals [12]. Moreover, garlic
also exerts anti-oxidant eﬀect during isoprenaline-induced
myocardial infarction in rat [13].
We recently reported improved survival and cardiac
function by add-on captopril [14, 15] and hydrochloroth-
iazide [16, 17] during garlic therapy in rats with myocar-
dial infarction. Our earlier experiment also demonstrated
increased therapeutic eﬃcacy of combined therapy of PRO
with garlic in animals subjected to myocardial damage
[18]. However, there is no scientiﬁc report to indicate the
biochemical alterations, antioxidant proﬁle, electrocardio-
graphic parameters, hemodynamic ﬁndings and histological
changes upon addition of PRO during chronic therapy of
garlic in hypertensive rats with myocardial damage. Also,
there is dearth of report on inﬂuence of garlic on phar-
macokinetic parameters of PRO in rats. Hence, the present
study was undertaken to evaluate the pharmacokinetic
and pharmacodynamic interactions of PRO with garlic in
rats.
2. Methods
2.1. Experimental Animals. Laboratory bred female Wistar
albino rats (200–250g) were housed at 25±5◦Ci naw e l l -
ventilated animal house under 12:12h light dark cycle.
The rats had free access to standard rat chow (Amrut
Laboratory Animal Feed, Maharashtra, India) containing (%
w/w) protein 22.10, oil 4.13, ﬁber 3.15, ash 5.15, sand (silica)
1.12 and water ad libitum. The institutional animal ethics
committee approved the experimental protocol and animals
were maintained under standard conditions in an animal
house approved by Committee for the Purpose of Control
and Supervision on Experiments on Animals (CPCSEA).
2.2. Preparation of Garlic Homogenate. Garlic (A. sativum,
family: Lilliaceae) bulbs were purchased from the local
vegetable market. The cloves were peeled, sliced, ground
into a paste and suspended in distilled water. Three dif-
ferent concentrations of the garlic homogenate (GH) were
prepared, 0.05, 0.1 and 0.2gml−1, corresponding to 125,
250 and 500mgkg−1 body weight of animal [12]. GH was
administered within 30min of preparation.
2.3. Fructose-Induced Hypertension. Seventy-two female
Wistar rats were divided into nine groups of eight animals
each. The group I was considered as control, given ordinary
drinking water ad libitum throughout the whole treatment
course and the remaining groups were given 10% fructose
solution to drink ad libitum [19]. Three weeks later,
the fructose-treated animals were assigned the following
treatment regimens: group II: fructose-fed (HF), group
III: fructose plus PRO (10mgkg−1, p.o.) [20] in the sixth
week, groups IV, V and VI were fed with fructose plus GH
125, 250 and 500mgkg−1,r e s p e c t i v e l yo r a l l yf o r3w e e k s ,
groups VII, VIII and IX were continued with fructose plus
GH 125, 250 and 500mgkg−1,r e s p e c t i v e l yo r a l l yf o r3
w e e k sa sw e l la sP R O( 1 0m gk g −1, p.o.) in the sixth week.
Fluid/food intake, body weight, heart rate and systolic blood
pressure (SBP) were measured every week. Concentrations
of glucose, cholesterol and triglycerides [21, 22] were also
measuredin plasma samples at theend of the 6 weeks of high
fructose.
2.4. Isoproterenol-Induced Myocardial Damage. At the end of
treatment and recordings as mentioned above, animals of
all groups except group I were administered isoproterenol
(ISO) (175mgkg−1 s.c.) for 2 consecutive days. Blood was
withdrawn from retroorbital vein 48h after the ﬁrst dose
of ISO under anesthesia and serum was separated by
centrifugation for lactate dehydrogenase (LDH) and crea-
tine phosphokinase-MB (CK-MB) measurement. The blood
pressure and ECG changes were recorded under appropriate
conditions. The heart was immediately isolated from each
animal under ketamine (70mgkg−1, i.p.) and xylazine
(10mgkg−1, i.p.) anesthesia. In each group consisting of
eight animals, four excised hearts were homogenized to pre-
pare heart tissue homogenate (HTH) using sucrose (0.25M)
[23]. The activity of LDH, CK-MB, superoxide dismutase
(SOD)[24]andcatalase[25]wer emeasur edinHTH.Micr o-
scopic slides of myocardium were prepared for histopatho-
logical studies from the hearts of remaining four animals.
The myocardial damage was determined by giving scores
depending on the intensity as follows [26]; no changes—
score 00; mild—score 01 (focal myocytes damage or small
multifocal degeneration with slight degree of inﬂammatory
process); moderate—score 02 (extensive myoﬁbrillar degen-
eration and/or diﬀuse inﬂammatory process); marked—
score 03 (necrosis with diﬀuse inﬂammatory process).
2.5. Blood Pressure and Electrocardiograms Measurement. As
discussed above, 48h after ﬁrst dose of ISO administration
just prior to collection of blood samples, mean arterial
blood pressure was measured in awaked animals by the non-
invasive blood pressure module (NIBP pressure meter, LE
5001, V02/0402L, Panlab, Hardvard apparatus, Barcelona,
Spain) and ECG was recorded in anesthetized animals
(ketamine (70mgkg−1, i.p.) and xylazine (10mgkg−1, i.p.))
by subcutaneous lead II method (Physiograph, EKG coupler,
SO-02, INCO, India), QRS duration, RR interval and QT
segment were measured.
2.6. Statistical Analysis. Results of pharmacodynamic para-
meters are expressed as mean±SEM. The statistical signif-
icance was determined using one-way analysis of variance
(ANOVA) followed by Bonferroni’s test. The results were
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2.7. Pharmacokinetic Interaction. Moderate dose of GH
(250mgkg−1, p.o.) was selected for pharmacokinetic inter-
action study as they were found to be more eﬀective
during pharmacodynamic evaluation. Animals were divided
into two groups consisting of eight animals each: group
I; PRO (PRO) 10mgkg−1 p.o. (single dose) and group II;
GH 250mgkg−1 for 30 days (p.o)+PRO (single dose).
Immediately after PRO administration, 0.5ml of blood
samples was withdrawn over 24h (0, 0.5, 1, 2, 4, 8, 16 and
24h) by puncturing retro orbital vein under ether anesthesia
and subjected to analysis. The hypovolemia is prevented by
intraperitoneal administration of 0.5ml of normal saline
immediately after each withdrawal of blood.
2.8. Extraction Procedure. The extraction buﬀer was
0.2moll−1 sodium carbonate, prepared by dissolving 21.2g
of sodium carbonate in 1l of distilled water. The extraction
solvent was butanol/hexane (20/80 by volume), both
“HPLC” grade. Ammonium sulphate buﬀer (10mmoll−1)
was prepared by dissolving 1.32g of ammonium sulphate
in 1l of doubly distilled water, then ﬁltering it through a
0.45μm (pore size) Millipore ﬁlter and adjusting the pH to
6.8. After 100μl of serum is mixed with 200μl of the internal
standard solution [N-(2-piperidylmethyl)-2,3-bis(2,2,2-
triﬂuoroethoxy)-benzamide HCl, 2500μgl −1] and 200μl
of 0.2moll−1 sodium carbonate, the sample is extracted
with butanol/hexane (20/80 by volume). The organic layer is
separated and evaporated, and the residue is redissolved in
200μl of methanol; 50μl of this is injected onto the column
[27].
2.9. Chromatographic Conditions. T h em o b i l ep h a s ef o rP R O
(PRO) was composed of acetonitrile (solvent A) and phos-
phate buﬀer (solvent B), with 0.2% (w:v) of triethylamine,
with the pH adjusted to 3 with orthophosphoric acid 85%
(0.067M, 40:60v:v, pH 3). The ﬂow rate was 0.8mlmin−1.
The UV detection was accomplished at 294nm at 0.05
AUFS and 0.5s response time. Standard solutions of active
principle were obtained by suitable dilution from stock
solutions prepared at 0.25mgml−1 in phosphate buﬀer (pH
7.4, 0.067M). The concentration range of the calibration
curves was 1–8μgml −1. The limits of quantitation were also
determined by suitable dilution from the lowest concentra-
tion of the calibration curve range [28].
2.10.PharmacokineticDetermination. Forthegenerateddata
on PRO and garlic interaction to be analyzed, we assume
that the kinetics of PRO elimination was linear [29]. The
data was represented in a plasma level-time curve from
where the area under time curve (AUC) was calculated
using Trapezoid rule. The maximum concentration (Cmax)
and maximum time (Tmax) were obtained directly from
generated data. The elimination constant (Ke) and half life
(T1/2) were determined from the semi-log plot of the data.
The clearance (CL) and apparent volume of distribution
(Vd) of the drug in the animals were calculated from
the equations, CL=Vd ×Ke, Vd is the administered dose
of drug/initial plasma concentration of drug obtained at
intercept of semi log plot of plasma drug sample. The mean
plasma concentration-time curve for PRO (10mgkg−1)
alone and PRO plus once a day administration of oral GH
(250mgkg−1) for 30 days was determined. The results were
analyzed statistically using Student’s t-test.
3. Results
3.1. Fluid Intake, Food Intake and Body Weight. Fluid intake,
food intake and body weight of the various groups of rats
at the end of 3 weeks and 6 weeks are shown in Figure 1.
High fructose for 3 weeks caused signiﬁcant increase in ﬂuid
intake as well as body weight with decrease in food intake
when compared to normal control. Treatment of animals
with PRO and GH (250mgkg−1), alone or together, found
to bring back the normal conditions in ﬂuid intake, body
weight and food intake, to signiﬁcant extent. The moderate
dose of GH (GH 250mgkg−1, p.o. for 3 weeks) was found to
be most eﬀective in ameliorating the abnormally increased
ﬂuid intake and body weight as well as decreased food intake
compared to HF control. Although, GH at low and high
doses (125 and 500mgkg−1, resp.) demonstrated signiﬁcant
fall in ﬂuid intake compared to HF control, but values were
still signiﬁcantly high when compared with normal control.
Incorporation of PRO in the sixth week of HF intake shows
synergistic eﬀect in reversing the normalcy in ﬂuid intake,
food intake and body weight when compared to HF control.
High and low doses of GH with or without PRO were less
eﬀective, whereas, moderate dose of GH was found to be
most eﬀe c t i v ea l o n ea sw e l la sa l o n gw i t hP R O .
3.2. SBP, Heart Rate, Cholesterol, Triglycerides and Glucose.
The changes in SBP, heart rate, cholesterol, triglycerides and
glucose in all the groups at the end of 6 weeks of high
fructose in ﬂuid are given in Figure 2.S i xw e e k so fH Fi n
water resulted in signiﬁcant elevation in SBP, heart rate,
cholesterol, triglycerides and glucose compared to normal
control. Administration of PRO and various doses of GH
demonstrated signiﬁcant fall in all parameters to varying
degrees when compared to HF control. The increased levels
of blood pressure, heart rate, cholesterol, triglycerides and
glucose were signiﬁcantly lowered in animals treated with
PRO (for 7 days during the sixth week of HF intake)
compared to HF control. The maximum protective eﬀect
was seen in combination therapy of GH (250mgkg−1,p . o .
from fourth to sixth week of HF intake) with PRO (PRO,
10mgkg−1, p.o. during the sixth week of HF intake) when
compared to HF control.
3.3. Electrocardiographic Parameters and Hemodynamic Find-
ings. High fructose intake for 6weeks with subsequent
administrationofISOshowedsigniﬁcantincreaseinSBPand
heart rate compared to normal control (Figure 3). Treatment
of animals with diﬀerent doses of GH and PRO caused
fall in SBP compared to HF control. The combination
of GH 250mgkg−1 with PRO showed more reduction in
SBP compared to their individual treatments. Moreover, the
chronotropic eﬀect was signiﬁcantly reduced in all treatment
groups compared to HF+ISO control. The combination
of GH 250mgkg−1 with PRO was more eﬀective than4 Evidence-Based Complementary and Alternative Medicine
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Figure 1:Fluidintake(mlkg−1 day−1),foodintake(gkg−1 day−1)andbodyweight(g)inrats.Allvaluesaremean ±SEM,n = 8, ∗∗∗P<. 001
when compared to normal control; •••P<. 001 when compared to HF control; aP<. 05 when compared to PRO (comparison between PRO
versusPRO+GH);HF,highfructose;PRO,propranolol,10mgkg−1,p.o.GH-125,250and500,garlichomogenate125,250and500mgkg−1,
p.o. ﬂuid intake (mgkg−1, p.o.) ﬂuid intake (mgkg−1 day−1); food intake gkg−1day−1 body weight (g).
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Figure 2: SBP (mmHg), heart rate (beatsmin−1), cholesterol (mgdl−1), triglycerides (mgdl−1) and glucose (mgdl−1)i nr a t s .A l lv a l u e sa r e
mean ± SEM, n = 8, ∗∗∗P<. 001 when compared to normal control; •••P<. 001 when compared to HF control; aP<. 05, aaP<. 01 when
compared to PRO (comparison between PRO versus PRO+GH); HF, high fructose; PRO, propranolol, 10mgkg−1 p.o. GH-125, 250 and
500, garlic homogenate 125, 250 and 500mgkg−1,p . o .
individual treatment in reducing inclined heart rate as
compared to HF+ISO control. The increased body weight
due to high fructose intake for 6 weeks plus two doses
of ISO was signiﬁcantly reduced in PRO and GH treated
groups as compared to HF+ISO control group. However,
GH 500mgkg−1 alone continued to show increased body
weight when compared to normal control, whereas, upon
addition of PRO, normal weight was attained. Signiﬁcant
changes in the ECG conﬁguration were seen in the rats with
HF+ISO treatment such as prolongation of QRS duration
withlongerQTsegmentandreducedRRintervals(Figure 4).
The PRO treated animals showed signiﬁcant prolongation of
QRScomplexcomparedtonormalcontrol.Thecombination
of GH 250mgkg−1 with PRO was found to signiﬁcantlyEvidence-Based Complementary and Alternative Medicine 5
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Figure 3: LDH activity and hemodynamic ﬁndings in rats. All values are mean ± SEM, n = 4/8, ∗∗P<. 01 ∗∗∗P<. 001 when compared to
normal control; •••P<. 001 when compared to HF control; aP<. 05 when compared to PRO (comparison between PRO versus PRO+GH);
HF, high fructose; PRO, propranolol, 10mgkg−1 p.o. GH, 125, 250 and 500, garlic homogenate 125, 250 and 500mgkg−1,p . o .
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Figure 4: Electrocardiographic parameters. All values are mean ± SEM, n = 8; ∗P<. 05, ∗∗∗P<. 001 when compared to normal control;
•P<. 05, •••P<. 001 when compared to HF control; aP<. 05 when compared to PRO (comparison between PRO versus PRO+GH); HF,
high fructose; PRO, propranolol, 10mgkg−1 p.o. GH, 125, 250 and 500, garlic homogenate 125, 250 and 500mgkg−1,p . o .
decrease the QRS complex compared to their individual
treatment. Fall in QT segment and normalization of RR
interval was seen with GH 250mgkg−1 alone or in presence
of PRO compared to HF+ISO control.
3.4. Biochemical Parameters, Antioxidants and Histological
Scores. High fructose ﬂuid for 6 weeks and subsequent ISO
administration for 2 days resulted in rise and fall in LDH and
CK-MB (Table 1) activities in serum and HTH respectively,
when compared to normal control. Oral administration
of PRO or diﬀerent doses of GH separately or together
resulted in fall in LDH and CK-MB activities in serum
and rise in HTH when compared to HF+ISO control. The
best results were found with combination of PRO with
GH 250mgkg−1 per oral, as there was signiﬁcant diﬀerence
in CK-MB activity between GH 250mgkg−1 alone and
PRO+GH 250mgkg−1. Table 1 also explains signiﬁcant fall
in SOD and Catalase activities with a rise in histological
scores of animals subjected to high fructose intake plus
ISO compared to normal control. The SOD and Catalase
activities of all GH treated groups were found to be increased
towards normal compared to HF+ISO control. However,6 Evidence-Based Complementary and Alternative Medicine
Table 1: CK-MB, LDH, SOD, catalase activities and histological scores in rats.
Treatments
CK-MB activity LDH activity HTH
Histological
scores Serum (Ul−1)
Heart tissue
homogenate
(Ug−1)
Serum (Ul−1)
Heart tissue
homogenate
(Ug−1)
SOD (Umg−1
protein)
Catalase
(Umg−1
protein)
Normal control 25.9±2 44.1±2 432±5 626±42 . 5 ±0.0 3.2±0.5 0.5±0.2
HF + ISO
control 38.4±1.8∗∗∗ 21.2±0.3∗∗∗ 565±5∗∗∗ 386±5∗∗∗ 1.5±0.4∗∗∗ 1.7±0.3∗∗∗ 2.6±0.2∗∗∗
HF + PRO 26.4±3∗••• 38.3±3∗••• 471±4•• 563±2••• 1.9±0.1••• 1.9±0.2∗•• 0.5±0.2∗••
HF + GH-125 27.3±1∗•• 40.2±2••• 415±3••• 542±3••• 2.2±0.3••• 2.5±0.4∗∗•• 0.5±0.2•••
HF + GH-250 25.2±2••• 42.6±1∗••• 421±7••• 618±9••• 2.4±0.5••• 3.1±0.3∗••• 0.5±0.2∗∗•••
HF + GH-500 28.8±1∗•• 38.8±1∗••• 459±5•• 531±7••• 2.3±0.1••• 2.8±0.6∗••• 1.0±0.3∗••
HF + GH-125 +
PRO 25.2±2••• 44.6±3••• 446±4••• 612±6••• 2.3±0.1•••aa 2.8±0.4•••aa 0.5±0.1•••
F + GH-250 +
PRO 24.3±3••• 46.4±3•••a 441±3••• 633±7••• 2.4±0.2•••aa 3.3±0.2•••aaa 0.3±0.2•••
HF + GH-500 +
PRO 25.4±5••• 44.5±5••• 459±7••• 613±8••• 2.2±0.1•••aa 2.9±0.3•••aa 0.5±0.1•••
All values are mean±SEM, n = 4/8; HF—high fructose; PRO—propranolol, 10mgkg−1, p.o. GH-125, 250 and 500—garlic homogenate 125, 250 and
500mgkg−1,p . o .
∗P<.05, ∗∗P<. 01, ∗∗∗P<. 001 when compared to normal control; ••P<. 01, •••P<. 001 when compared to HF control; aP<. 05, aaP<. 01, aaaP<. 001
when compared to PRO (comparison between PRO versus PRO+GH).
a b
c
d
Figure 5: H&E (×400) stained microscopic section of high fructose
(HF) plus isoproterenol (ISO) control. There is (a) loss of cellular
architecture, (b) nuclear duplication and (c) increased inﬁltration
of leucocytes with (d) prominent hyperchromasia.
incorporation of PRO during sixth week of high fructose
failed to provide any incline in SOD and Catalase activities
when compared to GH alone. The histological scores were
found to be reverted to normal condition in all treated
groups compared to HF+ISO control. There was loss
of cellular architecture, nuclear duplication and increased
inﬁltration of leucocytes with prominent hyperchromasia
in animals subjected to high fructose ﬂuid intake as well
as ISO (Figure 5). Normal cytoarchitecture of myocardium
was seen in animals treated with GH 250mgkg−1 during
the past 3 weeks of high fructose ﬂuid intake (Figure 6).
Microphotographs of animals provided protection of PRO
as well GH 250mgkg−1 shows normal cytoarchitecture of
myocardium with reduced interstitial space (Figure 7).
a
Figure 6: H&E (×400) stained microscopic section of heart tissue
of animals pretreated with GH 250mgkg−1 for 21 days orally.
Normal cytoarchitecture of myocardium is seen (a).
3.5. Pharmacokinetic Determination of PRO. As depicted in
Figure 8, Cmax and AUCtotal showed signiﬁcant diﬀerence
between the PRO alone and PRO+GH treated groups. The
time to reach peak (Tmax) in the plasma concentration of
PRO occurred at the same time in both groups, whereas
Cmax was substantially raised in presence of GH indicating
increased extent of absorption. There was signiﬁcant pro-
longation in elimination half-life T1/2 (h) in presence of
GH from 2.32 to 6.6. The PRO clearance was also reduced
signiﬁcantly from 5.26 to 1.72 (mlkg−1 h) in presence of GH.
It is also important to note that there was signiﬁcant fall in
the rate of absorption (Ka)o fP R Oi np r e s e n c eo fG H( f r o m
1.92 to 0.42). Moreover, elimination rate of PRO when co-
administered with GH was signiﬁcantly lowered (Table 2).Evidence-Based Complementary and Alternative Medicine 7
Table 2: Pharmacokinetic parameters of PRO in presence and
absence of GH.
Parameters PRO PRO + GH
Cmax (μgml −1)1 . 6 3 ±0.06 1.97±0.07∗
Tmax (h) 2.00±0.00 2.00±0.00
AUCtotal (μgh −1 ml−1)7 . 9 8 ±0.79 15.77±1.34∗∗
Ke (h−1) 0.3231±0.05 0.167±0.01∗∗∗
CL (mlkg−1 h−1)5 . 2 6 ±0.68 1.72±0.20∗∗∗
T1/2 (h) 2.32±0.50 6.67±0.79∗∗∗
Vd (mlkg−1) 16.71±1.10 16.15±0.23
Ka (h−1)1 . 3 2 ±0.22 0.67±0.09∗
Values are mean±SEM, n = 8; PRO means propranolol 10mgkg−1;G H
means Garlic homogenate 250mgkg−1. In PRO group-single dose of PRO
p.o. and in interactive group-30 days of GH treatment p.o. + single dose of
PRO p.o.
∗P<.05, ∗∗P<. 01, ∗∗∗P<. 001 when compared to PRO alone.
a
Figure 7: H&E (×400) stained microscopic section of heart tissue
of animals pretreated with GH 250mgkg−1 for 21 days orally and
subsequentlysubjectedtoPRO10mgkg−1 orallyfor7days.Normal
cytoarchitecture of myocardium with reduced interstitial space is
evident from the ﬁgure (a).
4. Discussion
The present study was undertaken to evaluate the pharma-
cokinetic and pharmacodynamic interaction of garlic with
PRO using experimental models in rats. The results observed
suggest that GH (250mgkg−1,p . o .) when combined with
PRO enhances the cardioprotective activity of latter during
myocardial damage induced by ISO in rats. It also explains
the ability of garlic to potentiate the antihypertensive actions
of PRO in high fructose (HF) induced hypertensive rats. The
bioavailability of PRO was remarkably increased when given
to animals previously treated with GH (250mgkg−1, p.o.).
Garlic (A. sativum) holds a unique position in history
and was recognized for its therapeutic potential. Garlic used
in the present study was purchased from the local vegetable
market that is the most widely used form. Among thousands
of published papers on the healing power of garlic, most of
them employed fresh GH, as it is the most common con-
sumable form for medicinal and non-medicinal purposes.
The dose of garlic was selected based on dose-dependent
study reported in earlier literature and later conﬁrmed by
our studies [14–18]. Garlic preparations contain a wide
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Figure 8: Plasma concentration of PRO in presence of garlic.
variety of organosulfuric compounds, S-allylcysteine (SAC),
N-Acetylcysteine (NAC) [30]a n dS-allylmercaptocysteine
(SAMC), which are mainly derived from alliin. When garlic
tissue is disrupted, the enzyme alliinase comes into contact
with alliin and catalyzes its breakdown into allicin [31–34].
Fresh GH is known to possess the highest concentration of
active constituent, allicin with half life up to 2.4days when
compared to normal half life of allicin, 2–16h [35, 36].
Allicin (allyl 2-propenethiosulﬁnate) was earlier thought to
be the principle bioactive compound responsible for the
cardioprotective eﬀect. However, recent studies suggest that
allicin is an unstable and transient compound with oxidant
activity [37] that is virtually undetectable in blood circula-
tion after garlic ingestion and decomposes to form the SAC
and SAMC [37] by reacting with an enzyme allinase or alliin
lyase,whichislocatedonlyinthevascularbundlesheathcells
[35]. GH was administered orally for 3weeks to avail bioac-
tivity of SAC and SAMC at highest level. The interaction
and counteraction could be attributed to the interference
of garlic in pharmacokinetic proﬁle of conventional drug,
PRO, PRO. Hence, the present investigation was undertaken
to demonstrate the alterations in pharmacokinetics and
pharmacodynamic of PRO, if any, in animals subjected to
chronic prophylactic administration of GH.
Oral PRO administration has poor bioavailability due
to extensive ﬁrst-pass metabolism. The bioavailability of
PRO may be increased by the concomitant ingestion of
food and during long-term administration of the drug.
The observations from our study demonstrate the role of
garlic in pharmacokinetics of PRO. The AUC and Cmax of
PRO were remarkably elevated in presence of GH indicating
signiﬁcant reduction in the ﬁrst pass metabolism of PRO in
presence of GH. Besides, reduced clearance and enhanced
T1/2 of PRO was seen in serum of animals pretreated with
GH. Our ﬁndings in the present research were in accordance
with their pharmacodynamic interactions that were reported8 Evidence-Based Complementary and Alternative Medicine
by us recently [18]. Even though the rate of absorption of
PRO was signiﬁcantly reduced in presence of GH, the Cmax
of PRO both in presence and absence of GH was found
to attain at the same time. Despite high Ka value, PRO
when administered alone was found to undergo massive
ﬁrst pass metabolism that might be the reason for increased
elimination, whereas, GH pretreatment causes slow rate of
absorption of PRO without eﬀecting the time to reach Cmax.
The resulting elevation in AUC with fall in elimination rate
could be due to enzyme inhibitory role of GH or by aﬀecting
the hepatic blood ﬂow. Hence the use of garlic during PRO
therapy should be monitored carefully with proper dose
adjustments.
High concentration of fructose in diet and ﬂuid has been
reported and proved to induce hypertension with insulin
resistance, impaired glucose tolerance and hyperinsulinemia
[38]. The use of 10% fructose in drinking water, for 3weeks
or longer appeared to be most suitable for rapid production
of fructose-induced hypertension [39]. The antihypertensive
ability of PRO was intact before and after induction of
myocardial damage and found to be potentiated when
garlic was administered prophylactically. The crucial role
of free radicals in pathogenesis of ISO induced myocardial
damage has been discussed by various studies [40, 41]. The
pathophysiological changes following ISO administration
are comparable to those taking place in human myocardial
alterations [26]. ISO induced myocardial damage is
associated with decreased endogenous antioxidants such
as superoxide dismutase (SOD) and catalase in serum that
are structurally and functionally impaired by free radicals
resulting in damage to myocardium [42]. Inclination in
endogenous antioxidant activities in HTH is indication for
structural integrity and protection to the myocardium that
is achieved by prior administration of GH. It is interesting to
notethealterationinSODiswithconcomitantﬂuctuationin
catalase after prior treatment of animals with GH. Elevated
activity of catalase in HTH is more beneﬁcial than increase
in SOD activity alone because without a simultaneous
increase in catalase activity, increased SOD activity may
lead to intracellular accumulation of H2O2 with detrimental
eﬀects [43]. One of our important ﬁnding of the present
study was maintenance of integrity of myocardium without
simultaneousriseinendogenousantioxidantslevelingroups
treated with PRO. Hence protection to myocardium during
ISO was not only due to elevation in antioxidants but also by
scavenging/preventing the formation of OFRs. PRO causes
decrease inﬂux of calcium across the cell membrane leading
to dephosphorylation of myosin light chain kinase. It deac-
tivates voltage sensitive calcium channels in the heart via Gs
mediated mechanism independent of cAMP concentration.
Therefore pacemaker activity and conduction velocity are
decreased with resultant increase in refractory period. As
it is known that oxidative phosphorylation is a central site
of reactive oxygen species production in the heart [44].
Therefore by dephosphorylation, generation of OFRs can be
drastically reduced. On the basis of the present observation,
it is speculated that PRO mediate cardioprotection without
signiﬁcantly elevating SOD or catalase activities in HTH but
by scavenging ability towards OFRs.
The membrane of myocardium was kept intact in
animals pre-treated with GH (250mgkg−1, p.o.) and PRO
as evident from elevated LDH and CK-MB activities in HTH
with depleted activities in serum. Damage to cardiac muscu-
lature was also demonstrated and conﬁrmed by histopatho-
logical scores. An increase in score is indicative of myocardial
damage [45]. Membrane stabilizing agent, PRO, was found
to decrease the histopathological scores alone as well as when
given along with cardioprotective, herb, garlic, in moder-
ate doses of 250mgkg−1 orally. The electrocardiographic
parameters and hemodynamic ﬁndings were normalized in
combination therapy especially RR interval and heart rate
was reverted to normal conditions as well as QRS duration
was reduced indicating protection from myocardial arrhyth-
mias induced by ISO. These results suggest the synergistic
behavior of PRO during GH mediated cardioprotection.
Higher doses of garlic might be containing more
amount of allicin. Normally, upon administration, allicin is
metabolically converted into safe active substances, SAC and
SAMC, which are found to be antioxidant. However, at high
concentration, allicin might not completely get converted
into these safe substances and hence we found marked
disturbance in biochemical and histological parameters at
higher doses [46, 47]. This is corroborating with number of
studiesongarlicjuiceandGHdemonstratinginjuriouseﬀect
of high dose of garlic on various tissues like intestinal lining
and stomach [48].
Hence from the above observations (Figure 9), the
moderate dose of GH and/or PRO provided remarkable
protection against high fructose in ﬂuid (10% fructose)-
induced hypertension by reducing triglycerides, cholesterol
and hyperglycemia. The combined therapy also attenuated
the ISO-mediated cardiac β1-receptors excessive stimulation
[49], thermogenesis [50], myocardial hypoperfusion [51],
glycogen depletion [52], electrolyte imbalance [53], lipid
accumulation [54], lipid peroxidation [54], electrocardio-
graphic disturbances [26] and free radical damage [55].
Therefore, it is possible that GH acts by enhancing the
endogenous antioxidant defense system and PRO by cur-
tailing the oxidative free radical generation, may maintain
the myocardial membrane integrity and thus prevent cardiac
dysfunction and hypertension. The results of the present
study indicate that combining PRO with GH (250mgkg−1,
p.o.) could provide an opportunity to reduce the dose and
frequency of PRO, which may help in minimizing repeated
higher doses of PRO.
5. Conclusion
In conclusion, this study revealed that garlic could cause
increase in the bioavailability and half life along with
decrease in the clearance and elimination rate constant of
PROwhentakenorally.Thismayposeanegativeimplication
in clinical practice as toxicity of PRO may easily be reached
especially during multiple dosing because of the possibility
of drug accumulation. However, careful addition of garlic
in moderate doses might result in beneﬁcial eﬀect during
treatment of hypertension in animals with myocardial stress.Evidence-Based Complementary and Alternative Medicine 9
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Figure 9: Mechanism of prevention of GH and PRO against fructose and isoproterenol induced hypertension and myocardial damage in
rats. Both GH and PRO individually and together were able to inhibit the progression of myocardial necrosis by acting at various stages in
the pathophysiology of hypertension and myocardial damage.
Hence, further studies should be carried out to determine
the inﬂuence of speciﬁc active constituent of GH when
combined with PRO in animals subjected to hypertension
and myocardial damage. We hope that this type of study will
open new areas of research for interaction and counteraction
between herb and conventional drugs when they are taken
concurrently.
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